We are monitoring the impact of COVID-19 on Latin America Genetic Testing Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 24
Share on
Share on

Latin America Genetic Testing Market Research Report – Segmented By Type, Application and Country (Brazil, Mexico, Argentina, Chile and Rest of Latin America) - Size, Share, Growth, Trends, And Forecast (2021 to 2026)

Pulished: April, 2021
ID: 24
Pages: 140

Latin America Genetic Testing Market Size (2021 to 2026)

The size of the Genetic testing market in Latin America was worth USD 4.22 billion in 2021 and is forecasted to reach USD 5.95 billion by 2026 growing at a CAGR of 7.12% during the forecast period.

Genetic Testing is an attractive and fast-growing segment in the molecular diagnostics market as it helps in providing superior medical care. Any modifications in chromosomes, genes, or proteins that are associated with the inherited disease conditions can be identified through genetic testing.

The risk of diseases like identifying carriers of disease, diagnosing diseases, or determining the likely course of a disease can be predicted through genetic testing, which is basically an analysis of genes, chromosomes, or proteins. Diseases such as sickle cell anemia, hemophilia, and cystic fibrosis are easily diagnosed with the help of genetic testing, making life easier for patients.

With it, the potential to be able to diagnose and treat diseases and growing awareness among individuals about its benefits has led to the growth of the Latin American genetic testing market. In addition, advancements in the genetic testing space, the aging population and a subsequent rise in the number of chronic diseases, and rising incidences of cancer are the other driving forces for the genetic testing market.

An increase in the incidence of genetic diseases unravels new opportunities for genetic testing and its related applications. The transformation of genetic testing from a service-driven market to a product-driven market is anticipated to provide a push to the diagnostic companies for expanding their operations.

However, few factors hinder the growth of the Latin American genetic testing market, including the high cost associated with genetic testing being one. And also, many individuals are concerned about the authenticity of genetic reports owing to the lack of a credible standard procedure.

This research report on the Latin American Genetic Testing Market has been segmented and sub-segmented into the following categories.

By Application: 

  • Cancer Testing
  • Pharmacogenomics Testing
  • Prenatal Testing
  • Predisposition Testing

By Test: 

  • Carrier Testing
  • Diagnostic Testing
  • Prenatal Testing
  • Neonatal Testing

By Country: 

  • Brazil
  • Argentina
  • Mexico
  • Chile
  • Rest of Latin America

KEY MARKET PLAYERS:

Companies that are playing a leading role in the Latin American Genetic Testing Market profiled in this report are Abbott Laboratories, Roche Molecular Diagnostics Inc., Abbott Molecular Inc., AutoGenomics Inc., Celera Group, ELITech Group, BioRad Laboratories, PerkinElmer Inc., Quest Diagnostics Inc., Transgenomic Inc., and Applied Biosystems Inc.

This report comes with:

  • Current and future LATAM Genetic Testing Market outlook in the developed and emerging markets
  • Analysis of various perspectives of the market with the help of Porter’s five forces analysis
  • Identifying the segment that is expected to dominate the market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, market shares, and strategies employed by the major market players
  • 3-month analyst support, along with the Market Estimate sheet (in Excel)

1.Introduction                  

                1.1 Market Definition    

                1.2 Study Deliverables  

                1.3 Base Currency, Base Year and Forecast Periods           

                1.4 General Study Assumptions

2. Research Methodology                           

                2.1 Introduction              

                2.2 Analysis Design         

                2.3 Research Phases      

                                2.3.1 Secondary Research

                                2.3.2 Primary Research

                                2.3.3 Econometric Modelling

                                2.3.4 Expert Validation

                2.4 Study Timeline          

3. Overview                      

                3.1 Executive Summary

                3.2 Key Inferences         

                3.3 New Developments

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                      

                4.1 Market Drivers          

                4.2 Market Restraints    

                4.3 Key Challenges         

                4.4 Current Opportunities in the Market

5. Market Segmentation                              

                5.1 By Type        

                                5.1.1 Carrier Testing

                                5.1.2 Diagnostic Testing

                                5.1.3 Prenatal Testing

                                5.1.4 Neonatal Testing

                5.2 By Application           

                                5.2.1 Cancer Testing

                                5.2.2 Prenatal Testing

                                5.2.3 Pharmacogenomics Testing

                                5.2.4 Presdisposition Testing

6. Geographical Analysis                              

                6.1 Introduction              

                6.2 Brazil             

                6.3 Argentina    

                6.4 Mexico         

                6.5 Rest of Latin America             

7.Strategic Analysis                        

                7.1 PESTLE analysis         

                                7.1.1 Political

                                7.1.2 Economic

                                7.1.3 Social

                                7.1.4 Technological

                                7.1.5 Legal

                                7.1.6 Environmental

                7.2 Porter’s Five analysis              

                                7.2.1 Bargaining Power of Suppliers

                                7.2.2 Bargaining Power of Consumers

                                7.2.3 Threat of New Entrants

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry

8.Market Leaders' Analysis                          

                8.1 Roche Molecular Diagnostics Inc.      

                                8.1.1 Overview

                                8.1.2 Product Analysis

                                8.1.3 Strategic Evaluation and Operations

                                8.1.4 Financial analysis

                                8.1.5 Legal issues

                                8.1.6 Recent Developments

                                8.1.7 SWOT analysis

                                8.1.8 Analyst View

                8.2 Abbott Laboratories

                8.3 AutoGenomics Inc. 

                8.4 Celera Group             

                8.5 ELITech Group          

                8.6 BioRad Laboratories

                8.7 Quest Diagnostics Inc             

                8.8 Transgenomic Inc.   

                8.9 Applied Biosystems Inc.,       

                8.10 PerkinElmer Inc      

9.Competitive Landscape                            

                9.1 Market share analysis            

                9.2 Merger and Acquisition Analysis        

                9.3 Agreements, collaborations and Joint Ventures          

                9.4 New Product Launches          

10.Expert Opinions                         

                10.1 Market Outlook     

                10.2 Investment Opportunities 

Appendix                           

                a) List of Tables

                b) List of Figures              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Latin America Genetic Testing Market By Region, From 2021 to 2026 (USD Billion)
  2. Latin America Genetic Testing Market By Type, From 2021 to 2026 (USD Billion)
  3. Latin America Carrier Testing Market By Region, From 2021 to 2026 (USD Billion)
  4. Latin America Diagnostic Testing Market By Region, From 2021 to 2026 (USD Billion)
  5. Latin America Prenatal Testing Market By Region, From 2021 to 2026 (USD Billion)
  6. Latin America Neonatal Testing Market By Region, From 2021 to 2026 (USD Billion)
  7. Latin America Genetic Testing Market By Application, From 2021 to 2026 (USD Billion)
  8. Latin America Cancer Testing Market By Region, From 2021 to 2026 (USD Billion)
  9. Latin America Prenatal Testing Market By Region, From 2021 to 2026 (USD Billion)
  10. Latin America Pharmacogenomics Testing Market By Region, From 2021 to 2026 (USD Billion)
  11. Latin America Predisposition Testing Market By Region, From 2021 to 2026 (USD Billion)
  12. Brazil Genetic Testing Market By Type, From 2021 to 2026 (USD Billion)
  13. Brazil Genetic Testing Market By Application, From 2021 to 2026 (USD Billion)
  14. Argentina Genetic Testing Market By Type, From 2021 to 2026 (USD Billion)
  15. Argentina Genetic Testing Market By Application, From 2021 to 2026 (USD Billion)
  16. Mexico Genetic Testing Market By Type, From 2021 to 2026 (USD Billion)
  17. Mexico Genetic Testing Market By Application, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample